デフォルト表紙
市場調査レポート
商品コード
1285890

ヘルスケアにおけるAI市場:世界の業界分析、規模、シェア、成長、動向、予測、2023~2031年

AI in Healthcare Market (Component: Software/Platform, and Services; End-user: Hospital & Healthcare Providers, Pharmaceuticals & Biotechnology Companies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日: | 発行: Transparency Market Research | ページ情報: 英文 320 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
ヘルスケアにおけるAI市場:世界の業界分析、規模、シェア、成長、動向、予測、2023~2031年
出版日: 2023年04月30日
発行: Transparency Market Research
ページ情報: 英文 320 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヘルスケアにおけるAI市場-レポートの範囲

TMRの調査レポートは、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。2023年を基準年、2031年を予測年として、2017年から2031年までの世界市場の収益を提供します。また、2023年から2031年までの世界市場の複合年間成長率(CAGR %)も掲載しています。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、ヘルスケアにおけるAI市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

このレポートは、世界のヘルスケアにおけるAI市場の競合情勢を詳しく掘り下げています。ヘルスケア市場における世界のAIで活動する主要企業が特定され、さまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界のヘルスケアにおけるAI市場のプレーヤーの属性です。

目次

第1章 序文

第2章 仮定と調査手法

  • 調査手法
    • 一次情報源と二次情報のリスト
  • データモデリングの重要な前提条件

第3章 エグゼクティブサマリー:世界市場

第4章 市場概要

  • 市場の定義
  • 技術/製品ロードマップ
  • 市場要因分析
  • COVID-19感染症の影響分析
  • 市場機会評価- 地域別(北米/欧州/アジア太平洋/中東およびアフリカ/南米)

第5章 世界市場の分析と予測

第6章 世界市場分析:コンポーネント別

  • 主要セグメント分析
  • 市場規模予測:コンポーネント別、2018年~2031年
    • ソフトウェア/プラットフォーム
    • サービス
      • マネージドサービス
      • プロフェッショナルサービス

第7章 世界市場分析:用途別

  • 主要セグメント分析
  • 市場規模予測:用途別、2018年~2031年
    • ロボット支援手術
    • バーチャル看護助手
    • 管理ワークフロー支援
    • 不正行為の検出
    • 投与量エラーの削減
    • 接続されたマシン
    • 臨床試験参加者識別子
    • 医療画像および診断
    • 創薬
    • その他

第8章 世界市場分析:エンドユーザー別

  • 主要セグメント分析
  • 市場規模予測:エンドユーザー別、2018年~2031年
    • 病院およびヘルスケア提供者
    • 製薬およびバイオテクノロジー企業
    • その他

第9章 世界市場の分析と予測:地域別

  • 主な調査結果
  • 地域別市場規模予測(2018~2031年)
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第10章 北米市場の分析と予測

第11章 欧州市場の分析と予測

第12章 アジア太平洋市場の分析と予測

第13章 中東およびアフリカ市場の分析と予測

第14章 南米市場の分析と予測

第15章 競合情勢

  • 市場競争マトリックス:有力企業別
  • 企業の階層構造別の競合情勢
  • 競合の規模、2022年
  • 2022年の地域レベルでの競合規模
  • 市場収益シェア分析(%):主要企業別(2022)
  • スタートアップ一覧
  • 競合の進化
    • 大規模な合併と買収、拡張、パートナーシップ、契約、取引など

第16章 企業プロファイル

  • IBM Corporation
    • COVID-19の影響
    • TMRの見解
    • 競合の脅威と弱み
  • NVIDIA Corporation
    • COVID-19の影響
    • TMRの見解
    • 競合の脅威と弱み
  • Microsoft Corporation
    • COVID-19の影響
    • TMRの見解
    • 競合の脅威と弱み
  • Intel Corporation
    • COVID-19の影響
    • TMRの見解
    • 競合の脅威と弱み
  • GE HealthCare
    • COVID-19の影響
    • TMRの見解
    • 競合の脅威と弱み
  • Siemens Healthineers AG
    • COVID-19の影響
    • TMRの見解
    • 競合の脅威と弱み
  • Medtronic Plc
    • COVID-19の影響
    • TMRの見解
    • 競合の脅威と弱み
  • Koninklijke Philips NV
    • COVID-19の影響
    • TMRの見解
    • 競合の脅威と弱み
  • Google LLC
    • COVID-19の影響
    • TMRの見解
    • 競合の脅威と弱み
  • CloudMinds Technology Inc.
    • COVID-19の影響
    • TMRの見解
    • 競合の脅威と弱み
  • General Vision Inc.
    • COVID-19の影響
    • TMRの見解
    • 競合の脅威と弱み
  • BenevolentAI
    • COVID-19の影響
    • TMRの見解
    • 競合の脅威と弱み
  • その他
    • COVID-19の影響
    • TMRの見解
    • 競合の脅威と弱み

第17章 要点

図表

List of Tables

  • Table 1: Acronyms Used in AI in Healthcare Market
  • Table 2: North America AI in Healthcare Market Revenue Analysis, by Country, 2023 and 2031 (US$ Bn)
  • Table 3: Europe AI in Healthcare Market Revenue Analysis, by Country, 2023 and 2031 (US$ Bn)
  • Table 4: Asia Pacific AI in Healthcare Market Revenue Analysis, by Country, 2023 and 2031 (US$ Bn)
  • Table 5: Middle East & Africa AI in Healthcare Market Revenue Analysis, by Country, 2023 and 2031 (US$ Bn)
  • Table 6: South America AI in Healthcare Market Revenue Analysis, by Country, 2023 and 2031 (US$ Bn)
  • Table 7: Forecast Factors: Relevance and Impact
  • Table 8: Impact Analysis of Drivers & Restraints
  • Table 9: Global AI in Healthcare Market Value (US$ Bn) Forecast, by Component, 2018 - 2031
  • Table 10: Global AI in Healthcare Market Value (US$ Bn) Forecast, by Application, 2018 - 2031
  • Table 11: Global AI in Healthcare Market Value (US$ Bn) Forecast, by End-user, 2018 - 2031
  • Table 12: Global AI in Healthcare Market Value (US$ Bn) Forecast, by Region, 2018 - 2031
  • Table 13: North America AI in Healthcare Market Value (US$ Bn) Forecast, by Component, 2018 - 2031
  • Table 14: North America AI in Healthcare Market Value (US$ Bn) Forecast, by Application, 2018 - 2031
  • Table 15: North America AI in Healthcare Market Value (US$ Bn) Forecast, by End-user, 2018 - 2031
  • Table 16: North America AI in Healthcare Market Value (US$ Bn) Forecast, by Country, 2018 - 2031
  • Table 17: U.S. AI in Healthcare Market Revenue CAGR Breakdown (%), by Growth Term
  • Table 18: Canada AI in Healthcare Market Revenue CAGR Breakdown (%), by Growth Term
  • Table 19: Mexico AI in Healthcare Market Revenue CAGR Breakdown (%), by Growth Term
  • Table 20: Europe AI in Healthcare Market Value (US$ Bn) Forecast, by Component, 2018 - 2031
  • Table 21: Europe AI in Healthcare Market Value (US$ Bn) Forecast, by Application, 2018 - 2031
  • Table 22: Europe AI in Healthcare Market Value (US$ Bn) Forecast, by End-user, 2018 - 2031
  • Table 23: Europe AI in Healthcare Market Value (US$ Bn) Forecast, by Country, 2018 - 2031
  • Table 24: Germany AI in Healthcare Market Revenue CAGR Breakdown (%), by Growth Term
  • Table 25: U.K. AI in Healthcare Market Revenue CAGR Breakdown (%), by Growth Term
  • Table 26: France AI in Healthcare Market Revenue CAGR Breakdown (%), by Growth Term
  • Table 27: Spain AI in Healthcare Market Revenue CAGR Breakdown (%), by Growth Term
  • Table 28: Italy AI in Healthcare Market Revenue CAGR Breakdown (%), by Growth Term
  • Table 29: Asia Pacific AI in Healthcare Market Value (US$ Bn) Forecast, by Component, 2018 - 2031
  • Table 30: Asia Pacific AI in Healthcare Market Value (US$ Bn) Forecast, by Application, 2018 - 2031
  • Table 31: Asia Pacific AI in Healthcare Market Value (US$ Bn) Forecast, by End-user, 2018 - 2031
  • Table 32: Asia Pacific AI in Healthcare Market Value (US$ Bn) Forecast, by Country, 2018 - 2031
  • Table 33: China AI in Healthcare Market Revenue CAGR Breakdown (%), by Growth Term
  • Table 34: India AI in Healthcare Market Revenue CAGR Breakdown (%), by Growth Term
  • Table 35: Japan AI in Healthcare Market Revenue CAGR Breakdown (%), by Growth Term
  • Table 36: ASEAN AI in Healthcare Market Revenue CAGR Breakdown (%), by Growth Term
  • Table 37: Middle East & Africa AI in Healthcare Market Value (US$ Bn) Forecast, by Component, 2018 - 2031
  • Table 38: Middle East & Africa AI in Healthcare Market Value (US$ Bn) Forecast, by Application, 2018 - 2031
  • Table 39: Middle East & Africa AI in Healthcare Market Value (US$ Bn) Forecast, by End-user, 2018 - 2031
  • Table 40: Middle East & Africa AI in Healthcare Market Value (US$ Bn) Forecast, by Country, 2018 - 2031
  • Table 41: Saudi Arabia AI in Healthcare Market Revenue CAGR Breakdown (%), by Growth Term
  • Table 42: United Arab Emirates AI in Healthcare Market Revenue CAGR Breakdown (%), by Growth Term
  • Table 43: South Africa AI in Healthcare Market Revenue CAGR Breakdown (%), by Growth Term
  • Table 44: South America AI in Healthcare Market Value (US$ Bn) Forecast, by Component, 2018 - 2031
  • Table 45: South America AI in Healthcare Market Value (US$ Bn) Forecast, by Application, 2018 - 2031
  • Table 46: South America AI in Healthcare Market Value (US$ Bn) Forecast, by End-user, 2018 - 2031
  • Table 47: South America AI in Healthcare Market Value (US$ Bn) Forecast, by Country, 2018 - 2031
  • Table 48: Brazil AI in Healthcare Market Revenue CAGR Breakdown (%), by Growth Term
  • Table 49: Argentina AI in Healthcare Market Revenue CAGR Breakdown (%), by Growth Term
  • Table 50: Mergers & Acquisitions, Partnerships (1/2)
  • Table 51: Mergers & Acquisitions, Partnerships (2/2)

List of Figures

  • Figure 1: Global AI in Healthcare Market Size (US$ Bn) Forecast, 2018-2031
  • Figure 2: Global AI in Healthcare Market Revenue (US$ Bn) Opportunity Assessment, by Region, 2023E
  • Figure 3: Top Segment Analysis of AI in Healthcare Market
  • Figure 4: Global AI in Healthcare Market Revenue (US$ Bn) Opportunity Assessment, by Region, 2031F
  • Figure 5: Global AI in Healthcare Market Attractiveness Assessment, by Component
  • Figure 6: Global AI in Healthcare Market Attractiveness Assessment, by Application
  • Figure 7: Global AI in Healthcare Market Attractiveness Assessment, by End-user
  • Figure 8: Global AI in Healthcare Market Attractiveness Assessment, by Region
  • Figure 9: Global AI in Healthcare Market Revenue (US$ Bn) Historic Trends, 2018 - 2021
  • Figure 10: Global AI in Healthcare Market Revenue Opportunity (US$ Bn) Historic Trends, 2018 - 2021
  • Figure 11: Global AI in Healthcare Market Value Share Analysis, by Component, 2023
  • Figure 12: Global AI in Healthcare Market Value Share Analysis, by Component, 2031
  • Figure 13: Global AI in Healthcare Market Absolute Opportunity (US$ Bn), by Software/Platform, 2023 - 2031
  • Figure 14: Global AI in Healthcare Market Absolute Opportunity (US$ Bn), by Services, 2023 - 2031
  • Figure 15: Global AI in Healthcare Market Value Share Analysis, by Application, 2023
  • Figure 16: Global AI in Healthcare Market Value Share Analysis, by Application, 2031
  • Figure 17: Global AI in Healthcare Market Absolute Opportunity (US$ Bn), by Robot-Assisted Surgery, 2023 - 2031
  • Figure 18: Global AI in Healthcare Market Absolute Opportunity (US$ Bn), by Virtual Nursing Assistants, 2023 - 2031
  • Figure 19: Global AI in Healthcare Market Absolute Opportunity (US$ Bn), by Administrative Workflow Assistance, 2023 - 2031
  • Figure 20: Global AI in Healthcare Market Absolute Opportunity (US$ Bn), by Fraud Detection, 2023 - 2031
  • Figure 21: Global AI in Healthcare Market Absolute Opportunity (US$ Bn), by Dosage Error Reduction, 2023 - 2031
  • Figure 22: Global AI in Healthcare Market Absolute Opportunity (US$ Bn), by Connected Machines, 2023 - 2031
  • Figure 23: Global AI in Healthcare Market Absolute Opportunity (US$ Bn), by Clinical Trial Participant Identifier, 2023 - 2031
  • Figure 24: Global AI in Healthcare Market Absolute Opportunity (US$ Bn), by Medical Imaging & Diagnostics, 2023 - 2031
  • Figure 25: Global AI in Healthcare Market Absolute Opportunity (US$ Bn), by Drug Discovery, 2023 - 2031
  • Figure 26: Global AI in Healthcare Market Absolute Opportunity (US$ Bn), by Others, 2023 - 2031
  • Figure 27: Global AI in Healthcare Market Value Share Analysis, by End-user, 2023
  • Figure 28: Global AI in Healthcare Market Value Share Analysis, by End-user, 2031
  • Figure 29: Global AI in Healthcare Market Absolute Opportunity (US$ Bn), by Hospital & Healthcare Providers, 2023 - 2031
  • Figure 30: Global AI in Healthcare Market Absolute Opportunity (US$ Bn), by Pharmaceuticals & Biotechnology Companies, 2023 - 2031
  • Figure 31: Global AI in Healthcare Market Absolute Opportunity (US$ Bn), by Others, 2023 - 2031
  • Figure 32: Global AI in Healthcare Market Opportunity (US$ Bn), by Region
  • Figure 33: Global AI in Healthcare Market Opportunity Share (%), by Region, 2023-2031
  • Figure 34: Global AI in Healthcare Market Size (US$ Bn), by Region, 2023 & 2031
  • Figure 35: Global AI in Healthcare Market Value Share Analysis, by Region, 2023
  • Figure 36: Global AI in Healthcare Market Value Share Analysis, by Region, 2031
  • Figure 37: North America AI in Healthcare Market Absolute Opportunity (US$ Bn), 2023 - 2031
  • Figure 38: Europe AI in Healthcare Market Absolute Opportunity (US$ Bn), 2023 - 2031
  • Figure 39: Asia Pacific AI in Healthcare Market Absolute Opportunity (US$ Bn), 2023 - 2031
  • Figure 40: Middle East & Africa AI in Healthcare Market Absolute Opportunity (US$ Bn), 2023 - 2031
  • Figure 41: South America AI in Healthcare Market Absolute Opportunity (US$ Bn), 2023 - 2031
  • Figure 42: North America Absolute Dollar Opportunity
  • Figure 43: North America AI in Healthcare Market Value Share Analysis, by Component, 2023
  • Figure 44: North America AI in Healthcare Market Value Share Analysis, by Component, 2031
  • Figure 45: North America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Software/Platform, 2023 - 2031
  • Figure 46: North America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Services, 2023 - 2031
  • Figure 47: North America AI in Healthcare Market Value Share Analysis, by Application, 2023
  • Figure 48: North America AI in Healthcare Market Value Share Analysis, by Application, 2031
  • Figure 49: North America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Robot-Assisted Surgery, 2023 - 2031
  • Figure 50: North America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Virtual Nursing Assistants, 2023 - 2031
  • Figure 51: North America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Administrative Workflow Assistance, 2023 - 2031
  • Figure 52: North America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Fraud Detection, 2023 - 2031
  • Figure 53: North America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Dosage Error Reduction, 2023 - 2031
  • Figure 54: North America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Connected Machines, 2023 - 2031
  • Figure 55: North America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Clinical Trial Participant Identifier, 2023 - 2031
  • Figure 56: North America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Medical Imaging & Diagnostics, 2023 - 2031
  • Figure 57: North America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Drug Discovery, 2023 - 2031
  • Figure 58: North America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Others, 2023 - 2031
  • Figure 59: North America AI in Healthcare Market Value Share Analysis, by End-user, 2023
  • Figure 60: North America AI in Healthcare Market Value Share Analysis, by End-user, 2031
  • Figure 61: North America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Hospital & Healthcare Providers, 2023 - 2031
  • Figure 62: North America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Pharmaceuticals & Biotechnology Companies, 2023 - 2031
  • Figure 63: North America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Others, 2023 - 2031
  • Figure 64: North America AI in Healthcare Market Value Share Analysis, by Country, 2023
  • Figure 65: North America AI in Healthcare Market Value Share Analysis, by Country, 2031
  • Figure 66: U.S. AI in Healthcare Market Opportunity Growth Analysis (US$ Bn) Forecast, 2023 - 2031
  • Figure 67: Canada AI in Healthcare Market Opportunity Growth Analysis (US$ Bn) Forecast, 2023 - 2031
  • Figure 68: Mexico AI in Healthcare Market Opportunity Growth Analysis (US$ Bn) Forecast, 2023 - 2031
  • Figure 69: Europe Absolute Dollar Opportunity
  • Figure 70: Europe AI in Healthcare Market Value Share Analysis, by Component, 2023
  • Figure 71: Europe AI in Healthcare Market Value Share Analysis, by Component, 2031
  • Figure 72: Europe AI in Healthcare Market Absolute Opportunity (US$ Bn), by Software/Platform, 2023 - 2031
  • Figure 73: Europe AI in Healthcare Market Absolute Opportunity (US$ Bn), by Services, 2023 - 2031
  • Figure 74: Europe AI in Healthcare Market Value Share Analysis, by Application, 2023
  • Figure 75: Europe AI in Healthcare Market Value Share Analysis, by Application, 2031
  • Figure 76: Europe AI in Healthcare Market Absolute Opportunity (US$ Bn), by Robot-Assisted Surgery, 2023 - 2031
  • Figure 77: Europe AI in Healthcare Market Absolute Opportunity (US$ Bn), by Virtual Nursing Assistants, 2023 - 2031
  • Figure 78: Europe AI in Healthcare Market Absolute Opportunity (US$ Bn), by Administrative Workflow Assistance, 2023 - 2031
  • Figure 79: Europe AI in Healthcare Market Absolute Opportunity (US$ Bn), by Fraud Detection, 2023 - 2031
  • Figure 80: Europe AI in Healthcare Market Absolute Opportunity (US$ Bn), by Dosage Error Reduction, 2023 - 2031
  • Figure 81: Europe AI in Healthcare Market Absolute Opportunity (US$ Bn), by Connected Machines, 2023 - 2031
  • Figure 82: Europe AI in Healthcare Market Absolute Opportunity (US$ Bn), by Clinical Trial Participant Identifier, 2023 - 2031
  • Figure 83: Europe AI in Healthcare Market Absolute Opportunity (US$ Bn), by Medical Imaging & Diagnostics, 2023 - 2031
  • Figure 84: Europe AI in Healthcare Market Absolute Opportunity (US$ Bn), by Drug Discovery, 2023 - 2031
  • Figure 85: Europe AI in Healthcare Market Absolute Opportunity (US$ Bn), by Others, 2023 - 2031
  • Figure 86: Europe AI in Healthcare Market Value Share Analysis, by End-user, 2023
  • Figure 87: Europe AI in Healthcare Market Value Share Analysis, by End-user, 2031
  • Figure 88: Europe AI in Healthcare Market Absolute Opportunity (US$ Bn), by Hospital & Healthcare Providers, 2023 - 2031
  • Figure 89: Europe AI in Healthcare Market Absolute Opportunity (US$ Bn), by Pharmaceuticals & Biotechnology Companies, 2023 - 2031
  • Figure 90: Europe AI in Healthcare Market Absolute Opportunity (US$ Bn), by Others, 2023 - 2031
  • Figure 91: Europe AI in Healthcare Market Value Share Analysis, by Country, 2023
  • Figure 92: Europe AI in Healthcare Market Value Share Analysis, by Country, 2031
  • Figure 93: Germany AI in Healthcare Market Opportunity Growth Analysis (US$ Bn) Forecast, 2023 - 2031
  • Figure 94: U.K. AI in Healthcare Market Opportunity Growth Analysis (US$ Bn) Forecast, 2023 - 2031
  • Figure 95: France AI in Healthcare Market Opportunity Growth Analysis (US$ Bn) Forecast, 2023 - 2031
  • Figure 96: Spain AI in Healthcare Market Opportunity Growth Analysis (US$ Bn) Forecast, 2023 - 2031
  • Figure 97: Italy AI in Healthcare Market Opportunity Growth Analysis (US$ Bn) Forecast, 2023 - 2031
  • Figure 98: Asia Pacific Absolute Dollar Opportunity
  • Figure 99: Asia Pacific AI in Healthcare Market Value Share Analysis, by Component, 2023
  • Figure 100: Asia Pacific AI in Healthcare Market Value Share Analysis, by Component, 2031
  • Figure 101: Asia Pacific AI in Healthcare Market Absolute Opportunity (US$ Bn), by Software/Platform, 2023 - 2031
  • Figure 102: Asia Pacific AI in Healthcare Market Absolute Opportunity (US$ Bn), by Services, 2023 - 2031
  • Figure 103: Asia Pacific AI in Healthcare Market Value Share Analysis, by Application, 2023
  • Figure 104: Asia Pacific AI in Healthcare Market Value Share Analysis, by Application, 2031
  • Figure 105: Asia Pacific AI in Healthcare Market Absolute Opportunity (US$ Bn), by Robot-Assisted Surgery, 2023 - 2031
  • Figure 106: Asia Pacific AI in Healthcare Market Absolute Opportunity (US$ Bn), by Virtual Nursing Assistants, 2023 - 2031
  • Figure 107: Asia Pacific AI in Healthcare Market Absolute Opportunity (US$ Bn), by Administrative Workflow Assistance, 2023 - 2031
  • Figure 108: Asia Pacific AI in Healthcare Market Absolute Opportunity (US$ Bn), by Fraud Detection, 2023 - 2031
  • Figure 109: Asia Pacific AI in Healthcare Market Absolute Opportunity (US$ Bn), by Dosage Error Reduction, 2023 - 2031
  • Figure 110: Asia Pacific AI in Healthcare Market Absolute Opportunity (US$ Bn), by Connected Machines, 2023 - 2031
  • Figure 111: Asia Pacific AI in Healthcare Market Absolute Opportunity (US$ Bn), by Clinical Trial Participant Identifier, 2023 - 2031
  • Figure 112: Asia Pacific AI in Healthcare Market Absolute Opportunity (US$ Bn), by Medical Imaging & Diagnostics, 2023 - 2031
  • Figure 113: Asia Pacific AI in Healthcare Market Absolute Opportunity (US$ Bn), by Drug Discovery, 2023 - 2031
  • Figure 114: Asia Pacific AI in Healthcare Market Absolute Opportunity (US$ Bn), by Others, 2023 - 2031
  • Figure 115: Asia Pacific AI in Healthcare Market Value Share Analysis, by End-user, 2023
  • Figure 116: Asia Pacific AI in Healthcare Market Value Share Analysis, by End-user, 2031
  • Figure 117: Asia Pacific AI in Healthcare Market Absolute Opportunity (US$ Bn), by Hospital & Healthcare Providers, 2023 - 2031
  • Figure 118: Asia Pacific AI in Healthcare Market Absolute Opportunity (US$ Bn), by Pharmaceuticals & Biotechnology Companies, 2023 - 2031
  • Figure 119: Asia Pacific AI in Healthcare Market Absolute Opportunity (US$ Bn), by Others, 2023 - 2031
  • Figure 120: Asia Pacific AI in Healthcare Market Value Share Analysis, by Country, 2023
  • Figure 121: Asia Pacific AI in Healthcare Market Value Share Analysis, by Country, 2031
  • Figure 122: China AI in Healthcare Market Opportunity Growth Analysis (US$ Bn) Forecast, 2023 - 2031
  • Figure 123: India AI in Healthcare Market Opportunity Growth Analysis (US$ Bn) Forecast, 2023 - 2031
  • Figure 124: Japan AI in Healthcare Market Opportunity Growth Analysis (US$ Bn) Forecast, 2023 - 2031
  • Figure 125: ASEAN AI in Healthcare Market Opportunity Growth Analysis (US$ Bn) Forecast, 2023 - 2031
  • Figure 126: Middle East & Africa Absolute Dollar Opportunity
  • Figure 127: Middle East & Africa AI in Healthcare Market Value Share Analysis, by Component, 2023
  • Figure 128: Middle East & Africa AI in Healthcare Market Value Share Analysis, by Component, 2031
  • Figure 129: Middle East & Africa AI in Healthcare Market Absolute Opportunity (US$ Bn), by Software/Platform, 2023 - 2031
  • Figure 130: Middle East & Africa AI in Healthcare Market Absolute Opportunity (US$ Bn), by Services, 2023 - 2031
  • Figure 131: Middle East & Africa AI in Healthcare Market Value Share Analysis, by Application, 2023
  • Figure 132: Middle East & Africa AI in Healthcare Market Value Share Analysis, by Application, 2031
  • Figure 133: Middle East & Africa AI in Healthcare Market Absolute Opportunity (US$ Bn), by Robot-Assisted Surgery, 2023 - 2031
  • Figure 134: Middle East & Africa AI in Healthcare Market Absolute Opportunity (US$ Bn), by Virtual Nursing Assistants, 2023 - 2031
  • Figure 135: Middle East & Africa AI in Healthcare Market Absolute Opportunity (US$ Bn), by Administrative Workflow Assistance, 2023 - 2031
  • Figure 136: Middle East & Africa AI in Healthcare Market Absolute Opportunity (US$ Bn), by Fraud Detection, 2023 - 2031
  • Figure 137: Middle East & Africa AI in Healthcare Market Absolute Opportunity (US$ Bn), by Dosage Error Reduction, 2023 - 2031
  • Figure 138: Middle East & Africa AI in Healthcare Market Absolute Opportunity (US$ Bn), by Connected Machines, 2023 - 2031
  • Figure 139: Middle East & Africa AI in Healthcare Market Absolute Opportunity (US$ Bn), by Clinical Trial Participant Identifier, 2023 - 2031
  • Figure 140: Middle East & Africa AI in Healthcare Market Absolute Opportunity (US$ Bn), by Medical Imaging & Diagnostics, 2023 - 2031
  • Figure 141: Middle East & Africa AI in Healthcare Market Absolute Opportunity (US$ Bn), by Drug Discovery, 2023 - 2031
  • Figure 142: Middle East & Africa AI in Healthcare Market Absolute Opportunity (US$ Bn), by Others, 2023 - 2031
  • Figure 143: Middle East & Africa AI in Healthcare Market Value Share Analysis, by End-user, 2023
  • Figure 144: Middle East & Africa AI in Healthcare Market Value Share Analysis, by End-user, 2031
  • Figure 145: Middle East & Africa AI in Healthcare Market Absolute Opportunity (US$ Bn), by Hospital & Healthcare Providers, 2023 - 2031
  • Figure 146: Middle East & Africa AI in Healthcare Market Absolute Opportunity (US$ Bn), by Pharmaceuticals & Biotechnology Companies, 2023 - 2031
  • Figure 147: Middle East & Africa AI in Healthcare Market Absolute Opportunity (US$ Bn), by Others, 2023 - 2031
  • Figure 148: Middle East & Africa AI in Healthcare Market Value Share Analysis, by Country, 2023
  • Figure 149: Middle East & Africa AI in Healthcare Market Value Share Analysis, by Country, 2031
  • Figure 150: Saudi Arabia AI in Healthcare Market Opportunity Growth Analysis (US$ Bn) Forecast, 2023 - 2031
  • Figure 151: United Arab Emirates AI in Healthcare Market Opportunity Growth Analysis (US$ Bn) Forecast, 2023 - 2031
  • Figure 152: South Africa AI in Healthcare Market Opportunity Growth Analysis (US$ Bn) Forecast, 2023 - 2031
  • Figure 153: South America Absolute Dollar Opportunity
  • Figure 154: South America AI in Healthcare Market Value Share Analysis, by Component, 2023
  • Figure 155: South America AI in Healthcare Market Value Share Analysis, by Component, 2031
  • Figure 156: South America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Software/Platform, 2023 - 2031
  • Figure 157: South America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Services, 2023 - 2031
  • Figure 158: South America AI in Healthcare Market Value Share Analysis, by Application, 2023
  • Figure 159: South America AI in Healthcare Market Value Share Analysis, by Application, 2031
  • Figure 160: South America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Robot-Assisted Surgery, 2023 - 2031
  • Figure 161: South America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Virtual Nursing Assistants, 2023 - 2031
  • Figure 162: South America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Administrative Workflow Assistance, 2023 - 2031
  • Figure 163: South America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Fraud Detection, 2023 - 2031
  • Figure 164: South America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Dosage Error Reduction, 2023 - 2031
  • Figure 165: South America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Connected Machines, 2023 - 2031
  • Figure 166: South America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Clinical Trial Participant Identifier, 2023 - 2031
  • Figure 167: South America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Medical Imaging & Diagnostics, 2023 - 2031
  • Figure 168: South America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Drug Discovery, 2023 - 2031
  • Figure 169: South America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Others, 2023 - 2031
  • Figure 170: South America AI in Healthcare Market Value Share Analysis, by End-user, 2023
  • Figure 171: South America AI in Healthcare Market Value Share Analysis, by End-user, 2031
  • Figure 172: South America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Hospital & Healthcare Providers, 2023 - 2031
  • Figure 173: South America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Pharmaceuticals & Biotechnology Companies, 2023 - 2031
  • Figure 174: South America AI in Healthcare Market Absolute Opportunity (US$ Bn), by Others, 2023 - 2031
  • Figure 175: South America AI in Healthcare Market Value Share Analysis, by Country, 2023
  • Figure 176: South America AI in Healthcare Market Value Share Analysis, by Country, 2031
  • Figure 177: Brazil AI in Healthcare Market Opportunity Growth Analysis (US$ Bn) Forecast, 2023 - 2031
  • Figure 178: Argentina AI in Healthcare Market Opportunity Growth Analysis (US$ Bn) Forecast, 2023 - 2031
目次
Product Code: TMRGL85584

AI in Healthcare Market - Scope of Report

TMR's report on the global AI in Healthcare Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global AI in Healthcare Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global AI in Healthcare Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the AI in Healthcare market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global AI in Healthcare market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global AI in Healthcare market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global AI in Healthcare market.

The report delves into the competitive landscape of the global AI in Healthcare market. Key players operating in the global AI in Healthcare Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global AI in Healthcare Market profiled in this report.

Key Questions Answered in Global AI in Healthcare Market Report:

  • What is the sales/revenue generated by AI in Healthcare across all regions during the forecast period?
  • What are the opportunities in the global AI in Healthcare market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

AI in Healthcare Market - Research Objectives and Research Approach

The comprehensive report on the global AI in Healthcare Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global AI in Healthcare Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global AI in Healthcare market.

Table of Contents

1. Preface

  • 1.1. Market Introduction
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives

2. Assumptions and Research Methodology

  • 2.1. Research Methodology
    • 2.1.1. List of Primary and Secondary Sources
  • 2.2. Key Assumptions for Data Modelling

3. Executive Summary: Global Artificial Intelligence (AI) in Healthcare Market

4. Market Overview

  • 4.1. Market Definition
  • 4.2. Technology/ Product Roadmap
  • 4.3. Market Factor Analysis
    • 4.3.1. Forecast Factors
    • 4.3.2. Ecosystem Analysis
    • 4.3.3. Market Dynamics (Growth Influencers)
      • 4.3.3.1. Drivers
      • 4.3.3.2. Restraints
      • 4.3.3.3. Opportunities
      • 4.3.3.4. Impact Analysis of Drivers and Restraints
  • 4.4. COVID-19 Impact Analysis
    • 4.4.1. Impact of COVID-19 on Artificial Intelligence (AI) in Healthcare Market
  • 4.5. Market Opportunity Assessment - by Region (North America/ Europe/ Asia Pacific/ Middle East & Africa/ South America)
    • 4.5.1. By Component
    • 4.5.2. By Application
    • 4.5.3. By End-user

5. Global Artificial Intelligence (AI) in Healthcare Market Analysis and Forecast

  • 5.1. Market Revenue Analysis (US$ Bn), 2017-2031
    • 5.1.1. Historic Growth Trends, 2017-2022
    • 5.1.2. Forecast Trends, 2023-2031

6. Global Artificial Intelligence (AI) in Healthcare Market Analysis, by Component

  • 6.1. Key Segment Analysis
  • 6.2. Artificial Intelligence (AI) in Healthcare Market Size (US$ Bn) Forecast, by Component, 2018 - 2031
    • 6.2.1. Software/Platform
    • 6.2.2. Services
      • 6.2.2.1. Managed Services
      • 6.2.2.2. Professional Services

7. Global Artificial Intelligence (AI) in Healthcare Market Analysis, by Application

  • 7.1. Key Segment Analysis
  • 7.2. Artificial Intelligence (AI) in Healthcare Market Size (US$ Bn) Forecast, by Application, 2018 - 2031
    • 7.2.1. Robot-assisted Surgery
    • 7.2.2. Virtual Nursing Assistants
    • 7.2.3. Administrative Workflow Assistance
    • 7.2.4. Fraud Detection
    • 7.2.5. Dosage Error Reduction
    • 7.2.6. Connected Machines
    • 7.2.7. Clinical Trial Participant Identifier
    • 7.2.8. Medical imaging & Diagnostics
    • 7.2.9. Drug Discovery
    • 7.2.10. Others

8. Global Artificial Intelligence (AI) in Healthcare Market Analysis, by End-user

  • 8.1. Key Segment Analysis
  • 8.2. Artificial Intelligence (AI) in Healthcare Market Size (US$ Bn) Forecast, by End-user, 2018 - 2031
    • 8.2.1. Hospital & Healthcare Providers
    • 8.2.2. Pharmaceuticals & Biotechnology Companies
    • 8.2.3. Others

9. Global Artificial Intelligence (AI) in Healthcare Market Analysis and Forecasts, by Region

  • 9.1. Key Findings
  • 9.2. Market Size (US$ Bn) Forecast by Region, 2018-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Middle East & Africa
    • 9.2.5. South America

10. North America Artificial Intelligence (AI) in Healthcare Market Analysis and Forecast

  • 10.1. Regional Outlook
  • 10.2. Artificial Intelligence (AI) in Healthcare Market Size (US$ Bn) Analysis and Forecast (2018 - 2031)
    • 10.2.1. By Component
    • 10.2.2. By Application
    • 10.2.3. By End-user
  • 10.3. Artificial Intelligence (AI) in Healthcare Market Size (US$ Bn) Forecast, by Country, 2018 - 2031
    • 10.3.1. U.S.
    • 10.3.2. Canada
    • 10.3.3. Mexico

11. Europe Artificial Intelligence (AI) in Healthcare Market Analysis and Forecast

  • 11.1. Regional Outlook
  • 11.2. Artificial Intelligence (AI) in Healthcare Market Size (US$ Bn) Analysis and Forecast (2018 - 2031)
    • 11.2.1. By Component
    • 11.2.2. By Application
    • 11.2.3. By End-user
  • 11.3. Artificial Intelligence (AI) in Healthcare Market Size (US$ Bn) Forecast, by Country/Sub-region, 2018 - 2031
    • 11.3.1. Germany
    • 11.3.2. UK
    • 11.3.3. France
    • 11.3.4. Italy
    • 11.3.5. Spain
    • 11.3.6. Rest of Europe

12. Asia Pacific Artificial Intelligence (AI) in Healthcare Market Analysis and Forecast

  • 12.1. Regional Outlook
  • 12.2. Artificial Intelligence (AI) in Healthcare Market Size (US$ Bn) Analysis and Forecast (2018 - 2031)
    • 12.2.1. By Component
    • 12.2.2. By Application
    • 12.2.3. By End-user
  • 12.3. Artificial Intelligence (AI) in Healthcare Market Size (US$ Bn) Forecast, by Country/Sub-region, 2018 - 2031
    • 12.3.1. China
    • 12.3.2. India
    • 12.3.3. Japan
    • 12.3.4. ASEAN
    • 12.3.5. Rest of Asia Pacific

13. Middle East & Africa Artificial Intelligence (AI) in Healthcare Market Analysis and Forecast

  • 13.1. Regional Outlook
  • 13.2. Artificial Intelligence (AI) in Healthcare Market Size (US$ Bn) Analysis and Forecast (2018 - 2031)
    • 13.2.1. By Component
    • 13.2.2. By Application
    • 13.2.3. By End-user
  • 13.3. Artificial Intelligence (AI) in Healthcare Market Size (US$ Bn) Forecast, by Country/Sub-region, 2018 - 2031
    • 13.3.1. Saudi Arabia
    • 13.3.2. United Arab Emirates
    • 13.3.3. South Africa
    • 13.3.4. Rest of Middle East & Africa

14. South America Artificial Intelligence (AI) in Healthcare Market Analysis and Forecast

  • 14.1. Regional Outlook
  • 14.2. Artificial Intelligence (AI) in Healthcare Market Size (US$ Bn) Analysis and Forecast (2018 - 2031)
    • 14.2.1. By Component
    • 14.2.2. By Application
    • 14.2.3. By End-user
  • 14.3. Artificial Intelligence (AI) in Healthcare Market Size (US$ Bn) Forecast, by Country/Sub-region, 2018 - 2031
    • 14.3.1. Brazil
    • 14.3.2. Argentina
    • 14.3.3. Rest of South America

15. Competition Landscape

  • 15.1. Market Competition Matrix, by Leading Players
  • 15.2. Competitive Landscape by Tier Structure of Companies
  • 15.3. Scale of Competition, 2022
  • 15.4. Scale of Competition at Regional Level, 2022
  • 15.5. Market Revenue Share Analysis (%), by Leading Players (2022)
  • 15.6. List of Startups
  • 15.7. Competition Evolution
    • 15.7.1. Major Mergers & Acquisitions, Expansions, Partnership, Contracts, Deals, etc.

16. Company Profiles

  • 16.1. IBM Corporation
    • 16.1.1. Business Overview
    • 16.1.2. Company Revenue
    • 16.1.3. Product Portfolio
    • 16.1.4. Geographic Footprint
    • 16.1.5. Recent Developments
    • 16.1.6. Impact of COVID-19
    • 16.1.7. TMR View
    • 16.1.8. Competitive Threats and Weakness
  • 16.2. NVIDIA Corporation
    • 16.2.1. Business Overview
    • 16.2.2. Company Revenue
    • 16.2.3. Product Portfolio
    • 16.2.4. Geographic Footprint
    • 16.2.5. Recent Developments
    • 16.2.6. Impact of COVID-19
    • 16.2.7. TMR View
    • 16.2.8. Competitive Threats and Weakness
  • 16.3. Microsoft Corporation
    • 16.3.1. Business Overview
    • 16.3.2. Company Revenue
    • 16.3.3. Product Portfolio
    • 16.3.4. Geographic Footprint
    • 16.3.5. Recent Developments
    • 16.3.6. Impact of COVID-19
    • 16.3.7. TMR View
    • 16.3.8. Competitive Threats and Weakness
  • 16.4. Intel Corporation
    • 16.4.1. Business Overview
    • 16.4.2. Company Revenue
    • 16.4.3. Product Portfolio
    • 16.4.4. Geographic Footprint
    • 16.4.5. Recent Developments
    • 16.4.6. Impact of COVID-19
    • 16.4.7. TMR View
    • 16.4.8. Competitive Threats and Weakness
  • 16.5. GE HealthCare
    • 16.5.1. Business Overview
    • 16.5.2. Company Revenue
    • 16.5.3. Product Portfolio
    • 16.5.4. Geographic Footprint
    • 16.5.5. Recent Developments
    • 16.5.6. Impact of COVID-19
    • 16.5.7. TMR View
    • 16.5.8. Competitive Threats and Weakness
  • 16.6. Siemens Healthineers AG
    • 16.6.1. Business Overview
    • 16.6.2. Company Revenue
    • 16.6.3. Product Portfolio
    • 16.6.4. Geographic Footprint
    • 16.6.5. Recent Developments
    • 16.6.6. Impact of COVID-19
    • 16.6.7. TMR View
    • 16.6.8. Competitive Threats and Weakness
  • 16.7. Medtronic Plc
    • 16.7.1. Business Overview
    • 16.7.2. Company Revenue
    • 16.7.3. Product Portfolio
    • 16.7.4. Geographic Footprint
    • 16.7.5. Recent Developments
    • 16.7.6. Impact of COVID-19
    • 16.7.7. TMR View
    • 16.7.8. Competitive Threats and Weakness
  • 16.8. Koninklijke Philips N.V.
    • 16.8.1. Business Overview
    • 16.8.2. Company Revenue
    • 16.8.3. Product Portfolio
    • 16.8.4. Geographic Footprint
    • 16.8.5. Recent Developments
    • 16.8.6. Impact of COVID-19
    • 16.8.7. TMR View
    • 16.8.8. Competitive Threats and Weakness
  • 16.9. Google LLC
    • 16.9.1. Business Overview
    • 16.9.2. Company Revenue
    • 16.9.3. Product Portfolio
    • 16.9.4. Geographic Footprint
    • 16.9.5. Recent Developments
    • 16.9.6. Impact of COVID-19
    • 16.9.7. TMR View
    • 16.9.8. Competitive Threats and Weakness
  • 16.10. CloudMinds Technology Inc.
    • 16.10.1. Business Overview
    • 16.10.2. Company Revenue
    • 16.10.3. Product Portfolio
    • 16.10.4. Geographic Footprint
    • 16.10.5. Recent Developments
    • 16.10.6. Impact of COVID-19
    • 16.10.7. TMR View
    • 16.10.8. Competitive Threats and Weakness
  • 16.11. General Vision Inc.
    • 16.11.1. Business Overview
    • 16.11.2. Company Revenue
    • 16.11.3. Product Portfolio
    • 16.11.4. Geographic Footprint
    • 16.11.5. Recent Developments
    • 16.11.6. Impact of COVID-19
    • 16.11.7. TMR View
    • 16.11.8. Competitive Threats and Weakness
  • 16.12. BenevolentAI
    • 16.12.1. Business Overview
    • 16.12.2. Company Revenue
    • 16.12.3. Product Portfolio
    • 16.12.4. Geographic Footprint
    • 16.12.5. Recent Developments
    • 16.12.6. Impact of COVID-19
    • 16.12.7. TMR View
    • 16.12.8. Competitive Threats and Weakness
  • 16.13. Others
    • 16.13.1. Business Overview
    • 16.13.2. Company Revenue
    • 16.13.3. Product Portfolio
    • 16.13.4. Geographic Footprint
    • 16.13.5. Recent Developments
    • 16.13.6. Impact of COVID-19
    • 16.13.7. TMR View
    • 16.13.8. Competitive Threats and Weakness

17. Key Takeaways